Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Àç¹ß¼º °áÀå ¹× Á÷Àå¾ÏÀÇ ¿Ü°úÀû Ä¡·á Surgical Treatment of Recurrent Colorectal Cancer

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2003³â 19±Ç 5È£ p.314 ~ 321
±¸±¤¸ð, ¹Ú»ó¼ö, À±Áø, ±èÀϸí, À¯º´¿í, ¾ç´ëÇö, Á¶ÀÍÇà,
¼Ò¼Ó »ó¼¼Á¤º¸
±¸±¤¸ð ( Koo Gwang-Mo ) 
Áö¹æ°ø»ç °­³²º´¿ø ¿Ü°ú

¹Ú»ó¼ö ( Park Sang-Su ) 
Áö¹æ°ø»ç °­³²º´¿ø ¿Ü°ú
À±Áø ( Yoon Jin ) 
Áö¹æ°ø»ç °­³²º´¿ø ¿Ü°ú
±èÀϸí ( Kim Il-Myoung ) 
Áö¹æ°ø»ç °­³²º´¿ø ¿Ü°ú
À¯º´¿í ( Yu Byoung-Uk ) 
Áö¹æ°ø»ç °­³²º´¿ø ¿Ü°ú
¾ç´ëÇö ( Yang Dae-Hyun ) 
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
Á¶ÀÍÇà ( Cho Ik-Hang ) 
µ¿ºÎ½Ã¸³º´¿ø ¿Ü°ú

Abstract


Purpose: Recurrent colorectal cancers have important and difficult diagnostic and treatment problems. The purpose of this study is to evaluate the rationale and the efficacy of surgical re-treatment for patients with recurrence following curative surgery for colorectal cancer.

Methods: From January 1991 to December 2002, we experienced 60 (20.9%) patients with recurred colorectal cancer among 287 patients who had curative operations in our hospital. These 60 patients were divided into three groups. Patients in group 1 had curative-intent resections, patients in group 2 had palliative resections, and patients in group 3 had conservertive treatment. The groups consisted of 17 (28.3%), 10 (16.7%) and 33 (55.0%) patients, respectively. We analyzed retrospectively those groups for any recurrence pattern and for survival.

Results: Of the 60 patients with recurrent colorectal cancer, in 20 (33.3%) patients the cancer recurred in the colon, and in 40 (66.7%) it recurred in the rectum. Local recurrence was seen in 9 (15.0%) patients, liver metastasis in 25 (41.7%), and pulmonary metastasis in 13 (21.7%). The 1- and 3-, and 5-year survival rates were 86.5%, 31.7%, and 15.9%, respectively, for group 1, 33.3%, 0%, and 0% for group 2, and 28.9%, 4.4%, and 4.4% for group 3. The median survival period was 31 months for group 1, 8 months for group 2, and 7 months for group 3.

Conclusion: Although evaluation was difficult owing to the small number of patients with recurrent colorectal cancer, a significant difference in survival rates was observed between the treatment groups. On the basis of these results, we think that curative-intent aggressive surgery for recurrent colorectal cancer in appropriately selected cases can clearly prolong survival when compared with palliative resections and conservative treatment.

Å°¿öµå

°áÀåÁ÷ÀåÁ¾¾ç;»ýÁ¸À²;±¹¼ÒÁ¾¾ç Àç¹ß
Colorectal Neoplasm;Survival rate;Neoplasm recurrent;Local

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS